Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Skin Neoplasms 2Recurrence 1Nevus, Pigmented 1Melanoma 1Margins of Excision 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 16Nivolumab 15Ipilimumab 12cemiplimab 10aldesleukin 6Interleukin-2 6Cyclophosphamide 6fludarabine 5fludarabine phosphate 4encorafenib 4binimetinib 4Blood Specimen Collection 4avelumab 3Sirolimus 3trametinib 2spartalizumab 2lifileucel 2dabrafenib 2atezolizumab 2Vemurafenib 2Surgical Procedures, Operative 2Specimen Handling 2Radiotherapy 2Prednisone 2Niacinamide 2Exercise 2Everolimus 2Dermoscopy 2Biopsy 2urelumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Skin Neoplasms × Dermoscopy × 1 year × Clear all
NCT07361666 2026-01-23

HFUS-CLEAR

Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji

Not yet recruiting
400 enrolled
Dermatologic

Margins of Excision, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Recurrence, Skin Neoplasms

NCT05321784 2025-12-29

At-Home Dermoscopy Artificial Intelligence

OHSU Knight Cancer Institute

Phase NA Terminated
1 enrolled 5 charts
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡